| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd, Inc. (TXMD) has 4 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. TXMD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 67.5K | $133.6K | - | |
| ? | 23.2K | $45.9K | - | |
| ? | 8.5K | $16.8K | - | |
| ? | 8.5K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | Krassan Mitchell | Chief Strategy Officer | Sale+OE | 300,000 | $2.26 | $676,920.00 | -100% | |
| Oct 25, 2019 | Milligan John C.K. IV | President/ Secretary | Buy | 72,000 | $2.75 | $198,000.00 | +4.9% | |
| Oct 25, 2019 | Milligan John C.K. IV | President/ Secretary | Buy | 72,000 | $2.75 | $198,000.00 | +4.9% | |
| Oct 25, 2019 | Finizio Robert G | CEO | Buy | 72,000 | $2.75 | $198,000.00 | +0.4% | |
| Oct 25, 2019 | Bernick Brian | Director | Buy | 36,000 | $2.75 | $99,000.00 | +58.1% | |
| Aug 23, 2019 | Russell Angus C. | Director | Buy | 10,000 | $2.77 | $27,700.00 | +12.0% | |
| Aug 20, 2019 | Finizio Robert G | CEO | Buy | 35,000 | $2.74 | $95,900.00 | +0.2% | |
| Aug 16, 2019 | Milligan John C.K. IV | President/ Secretary | Buy | 10,000 | $2.93 | $29,300.00 | +0.3% | |
| Aug 15, 2019 | Russell Angus C. | Director | Buy | 35,000 | $2.83 | $98,900.00 | +28.7% | |
| Aug 12, 2019 | Milligan John C.K. IV | President/ Secretary | Buy | 15,000 | $3.16 | $47,400.00 | +0.4% |